Smartway Pharmaceuticals Limited Sustainability Profile
Smartway Pharmaceuticals Limited, headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in the early 2000s, the company has achieved significant milestones, establishing a strong presence in both domestic and international markets. With a focus on prescription medications and over-the-counter products, Smartway Pharmaceuticals is renowned for its commitment to quality and efficacy. Their unique formulations and patient-centric approach set them apart in a competitive landscape. The company has garnered recognition for its robust research and development initiatives, positioning itself as a trusted name in healthcare. Smartway Pharmaceuticals Limited continues to expand its portfolio, striving to meet the evolving needs of patients and healthcare providers alike, while maintaining a strong market position through strategic partnerships and a dedication to innovation.
DitchCarbon Score
How does Smartway Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Smartway Pharmaceuticals Limited's score of 26 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Smartway Pharmaceuticals Limited's reported carbon emissions
Smartway Pharmaceuticals Limited, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Smartway Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. In the context of the pharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability practices to mitigate climate impact. However, without specific emissions data or reduction initiatives, it is unclear how Smartway Pharmaceuticals aligns with these industry trends. As the company moves forward, establishing measurable climate commitments could enhance its sustainability profile and contribute to broader environmental goals.
How Carbon Intensive is Smartway Pharmaceuticals Limited's Industry?
How Carbon Intensive is Smartway Pharmaceuticals Limited's Location?
Smartway Pharmaceuticals Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Smartway Pharmaceuticals Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
